Allovir Inc (NQ: ALVR )
3.720 -0.170 (-4.37%) Streaming Delayed Price Updated: 4:00 PM EDT, May 30, 2023 Add to My Watchlist
All News about Allovir Inc
AlloVir: Q1 Earnings Insights
May 04, 2023
AlloVir Reports First Quarter 2023 Financial Results
May 04, 2023
AlloVir's Posoleucel Achieves Non-Relapse Mortality Of 0% In Transplant Patients For Viral Infections
April 26, 2023
AlloVir Inc (NASDAQ: ALVR) announced the presentation of long-term, follow-up data from the Phase 2 study of posoleucel to prevent infections from six viruses in allogeneic hematopoietic cell...
AlloVir Appoints Derek Adams, Ph.D., to Board of Directors
February 23, 2023
AlloVir Reports Full-Year 2022 Financial Results and 2023 Outlook
February 15, 2023
AlloVir to Participate in the SVB Securities Global Biopharma Conference
February 01, 2023
AlloVir Reports Third Quarter 2022 Financial Results
November 03, 2022
Why Super Micro Computer Shares Jumped Over 10%; Here Are 73 Biggest Movers From Yesterday
October 21, 2022
Gainers NextPlay Technologies, Inc. (NASDAQ: NXTP) shares climbed 107.3% to close at $0.4138 on Thursday after the company announced its NextFintech division received commitment for a $15 million...
12 Health Care Stocks Moving In Wednesday's Intraday Session
August 31, 2022
12 Health Care Stocks Moving In Thursday's Intraday Session
August 11, 2022
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session
August 09, 2022
Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD....
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following